IMPLANT SITE EXTRAVASATION

This adverse event was reported 786 times

These drugs are most commonly taken by patients reporting IMPLANT SITE EXTRAVASATION:

# Drug Count
0 BACLOFEN 225
1 BACLOFEN INJECTION 125
2 BUPIVACAINE 64
3 BUPIVACAINE HYDROCHLORIDE IN DEXTROSE 63
4 HYDROMORPHONE HYDROCHLORIDE 61
5 CLONIDINE 49
6 MORPHINE 30
7 FENTANYL 29
8 IBUPROFEN 26
9 GABAPENTIN 24
See all common drugs associated with IMPLANT SITE EXTRAVASATION

IMPLANT SITE EXTRAVASATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BARRIER CREAM 1 0.0588
1 BACLOFEN INJECTION 125 0.0401
2 SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC 1 0.0122
3 METHENAMINE MANDELATE 2 0.0107
4 BUPIVACAINE HYDROCHLORIDE IN DEXTROSE 63 0.0083
5 ZICONOTIDE ACETATE 19 0.0078
6 BUPIVACAINE 64 0.0068
7 BACLOFEN 225 0.0026
8 BARIUM SULFATE 1 0.0023
9 DANTROLENE SODIUM 2 0.0017
See all drugs enriched for association with IMPLANT SITE EXTRAVASATION

IMPLANT SITE EXTRAVASATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 gamma-Aminobutyric Acid-ergic Agonist [EPC] 340 0.0038
1 Central alpha-2 Adrenergic Agonist [EPC] 49 0.0009
2 Amide Local Anesthetic [EPC] 65 0.0007
3 Antihypoglycemic Agent [EPC] 2 0.0005
4 mu-Opioid Receptor Agonist [EPC] 1 0.0003
5 Plasma Volume Expander [EPC] 1 0.0003
6 Rifamycin Antimycobacterial [EPC] 1 0.0003
7 Opioid Agonist [EPC] 67 0.0002
8 Androgen [EPC] 5 0.0002
9 Barbiturate [EPC] 2 0.0002
See all drug classes enriched for association with IMPLANT SITE EXTRAVASATION